Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur

Inclusion Criteria: * Males and females age 18 years or more * X-ray confirming basicervical, pertrochanteric or subtrochanteric femur fracture and planning operation with DHS or PFN. * Subjects must have 7 or more points in the Hindsøes test. Exclusion Criteria: * Subjects where spinal anaesthesia cannot be applied. * Subject in Plavix® treatment seven days before admission to the hospital. * Subjects with extracapsular hip fracture due to bone metastasis. * Subjects with a BMI over 30. * Subjects under 45 kg. * Subjects who are currently taking monoamine oxidase inhibitors (MAOIs) or have taken MAOIs within 2 weeks prior admission to the hospital. * Substance or alcohol abuse, or subjects who, in the opinion of the investigator have demonstrated addictive or substance abuse behavior. * Untreated depression or other psychiatric disorder in such a way that participation in the study may in the opinion of the investigator pos an unacceptable risk to the subject. * Dermatological disorder at any relevant patch application site. * Any contraindications listed in the Summary of Product Characteristics for Norspan®, OxyNorm® and OxyContin®. * Patient does not tolerate oxynorm. * User of wheelchair. * Daily use of morphine before hospitalization. * More than one fracture. Patients with myasthenia gravis. Patients with severe respiratory function. Patients know need re-operation women of childbearing potential must have a negative pregnancy test and be non-lactating